The Case Report of a Child with High-Risk Acute Lymphoblastic Leukemia, Treated with Allogenic Peripheral Blood Stem Cell Transplantation
Journal of the Korean Pediatric Society
;
: 1505-1508, 2000.
Article
in Korean
| WPRIM
| ID: wpr-34977
ABSTRACT
Allogenic peripheral blood stem cell transplantation could be used instead of allogenic bone marrow in treatment of leukemia in children. This 10-year-old female patient with high-risk acute lymphoblastic leukemia received a myeloablative regimen followed by allogenic peripheral blood stem cell transplantation from an HI A-identical sibling donor. Neutrophil recovery to greater than 500/pL occurred at day 11 and platelets recovered to greater than 20,000/pL at day 13. Allogenic peripheral blood stem cell transplantation can be performed safely and may result in a rapid neutrophil and platelet engraftment, without any apparent increased risk of acute graft versus host disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tissue Donors
/
Blood Platelets
/
Bone Marrow
/
Leukemia
/
Peripheral Blood Stem Cell Transplantation
/
Siblings
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Graft vs Host Disease
/
Neutrophils
Type of study:
Etiology study
Limits:
Child
/
Female
/
Humans
Language:
Korean
Journal:
Journal of the Korean Pediatric Society
Year:
2000
Type:
Article
Similar
MEDLINE
...
LILACS
LIS